Cartography Biosciences partners with Pfizer to discover tumour-selective antigens

BostonGene and AstraZeneca collaborate to advance AI-driven oncology development

RedHill advances RHB-102 across GI indications

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

BioInvent reports encouraging Phase 2a data for BI-1808 plus pembrolizumab in recurrent ovarian cancer

Hoth Therapeutics files two US provisional patent applications to establish oncology-focused dermatology platform

Insilico Medicine signs multi-year research and development collaboration with Servier

MemorialCare hospitals recognised in 2026 Women's Choice Awards

International Isotopes Inc to change name to Radnostix Inc

Delcath publishes Phase 3 FOCUS subgroup data supporting HEPZATO in metastatic uveal melanoma

Corcept announces receipt of FDA Complete Response letter for relacorilant in hypercortisolism

Sensiva Health names new chief operating officer

HUTCHMED savolitinib NDA for MET-amplified gastric cancer accepted for priority review in China

SOFIE Biosciences reports first patient dosed Phase 3 clinical trial of [18F]FAPI-74

ABL Bio receives upfront payment and equity investment from Eli Lilly